ANAVEX 3-71

N/A

Report date: 2024/06/20 15:59:49
NME

Base Information

Drug NameANAVEX 3-71
Drug Alias NameAF-710BANAVEX 3-71
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSigma opioid receptor agonistsMuscarinic acetylcholine receptor M1 agonists
TargetsSigma opioid receptorMuscarinic acetylcholine receptor M1
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A